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In this communication, the contribution of stromal, or non-hematopoietic, cells to the struc-
ture and function of lymph nodes (LNs), as canonical secondary lymphoid organs (SLOs),
is compared to that of tertiary lymphoid tissue or organs (TLOs), also known as ectopic
lymphoid tissues.TLOs can arise in non-lymphoid organs during chronic inﬂammation, as a
result of autoimmune responses, graft rejection, atherosclerosis, microbial infection, and
cancer.The stromal components found in SLOs including follicular dendritic cells, ﬁbroblast
reticular cells, lymphatic vessels, and high endothelial venules and possibly conduits are
present in TLOs; their molecular regulation mimics that of LNs. Advances in visualization
techniques and the development of transgenic mice that permit in vivo real time imaging of
these structures will facilitate elucidation of their precise functions in the context of chronic
inﬂammation. A clearer understanding of the inﬂammatory signals that drive non-lymphoid
stromal cells to reorganize into TLO should allow the design of therapeutic interventions
to impede the progression of autoimmune activity, or alternatively, to enhance anti-tumor
responses.
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INTRODUCTION
The non-hematopoietic or stromal cells present in secondary
lymphoid organs (SLOs) – lymph nodes (LNs), spleen, Peyer’s
patches (PP)- provide the structural and functional underpin-
nings that allow the most efﬁcient encounter of lymphocytes with
their cognate antigens. In this communication, we compare and
analyze the contribution of stromal cells in SLOs to a particu-
lar type of cellular accumulation, the tertiary lymphoid tissue/
organ (TLO).
The immune system generates a repertoire of antigen speciﬁc
lymphocytes during development of these cells in primary lym-
phoid organs (the thymus, fetal liver, and bone marrow). Mature
lymphocytes regularly transit through SLOs where encounter with
cognate antigen is facilitated, leading to an effective immune
response. Strategically positioned throughout the body, LNs are
encapsulated, highly organized structures; T cells and dendritic
cells (DCs) are concentrated in the paracortical region, with B
cells and follicular DCs (FDCs) in the cortical region. In the
mature LN, resident stromal cells play several critical roles, pro-
viding: (1) a meshwork supporting lymphocyte attachment, (2)
chemokine signals directing cell subset positioning, (3) a gateway
for entrance for lymphocytes (high endothelial venules; HEVs),
(4) connections between nodes (lymphatic vessels; LVs), (5) entry
points for antigen and antigen presenting cells (APCs; afferent
LVs), (6) microvessels, allowing rapid import of small antigens
and chemical signals (conduits formed by ﬁbroblastic reticular
cells; FRCs), and (7) sites of self-antigen presentation (FRCs,
eTACs, LVs).
While SLOs arise during development at key locations in
the body, chronic immune activity in the adult can give rise
to similar organized accumulations of lymphoid cells in almost
any non-lymphoid tissue. These TLOs closely resemble SLOs
(particularly LNs) with regard to cellular composition, orga-
nization, chemokines, and vasculature. TLOs have been noted
during chronic inﬂammatory processes, including autoimmu-
nity, chronic graft rejection, persistent infection (summarized
in Drayton et al., 2006), atherosclerosis (Grabner et al., 2009),
and cancer (Martinet et al., 2011; Bergomas et al., 2012). TLOs
can also be induced experimentally by tissue-speciﬁc expres-
sion of certain inﬂammatory mediators (summarized in Drayton
et al., 2006), including members of the lymphotoxin (LT) fam-
ily (Kratz et al., 1996; Drayton et al., 2003), cytokines crucial for
lymphoid organ development and maintenance (Ruddle and Aki-
rav, 2009). Like SLOs, TLOs display organized leukocyte subtype
compartmentalization driven by lymphoid chemokines (CCL19,
CCL21, and CXCL13), the formation of germinal centers, and a
highly organized vascular system, including HEVs, LVs, and per-
haps conduits (Figure 1). Data suggesting that TLOs function
as local sites of antigen presentation and lymphocyte activa-
tion, including somatic hypermutation and class switching in B
cells (Schroder et al., 1996), suggest that they facilitate local anti-
microbial responses, as well as epitope spreading (McMahon et al.,
2005) and autoimmune exacerbation.
Not all inﬂammatory inﬁltrates organize into TLOs. Further-
more, in some instance, TLOs can progress froma relatively benign
to a destructive phase. In type 1 diabetes in the NOD mouse, initial
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FIGURE 1 | A comparison of a lymph node with aTLO, a salivary gland from an individual with Sjögren’s syndrome. Note that the HEVs and lymphatic
vessels are colored to indicate the existence of mice with green ﬂuorescent HEVs (Bentley et al., 2011) and red ﬂuorescent lymphatic vessels (Truman et al.,
2012) that have been developed to facilitate in vivo imaging.
pancreatic inﬁltrates are characterized by HEV development and
minimal islet destruction, whereas later stages demonstrate frank
islet destruction and diabetes (Andre et al., 1996). In this model,
pancreaticTLOsdisappear after removal of theβ cell antigen, being
replaced by tissue ﬁbroblasts.
In the following sections, we present a detailed comparison of
the stromal characteristics of SLOs and TLOs.
LYMPHOID TISSUE ORGANIZER CELLS
In the early stages of SLO development, various initiating events
can activate stromal cells, called lymphoid tissue organizer
(LTo) cells (CD4−CD3−IL7+VCAM-1+CXCL13+LTβR+), which
recent data suggest may be derived from adipocyte precursors
(Bénézech et al., 2012). LTo cells then activate lymphoid tissue
inducer (LTi) cells (CD4+CD3−LTαβ+, IL7R+ CXCR5+) and they
in turn, by their cytokine production, activate LTo cells. Although,
LTo cells have not yet been isolated from TLOs, LTβR has been
shown to induce aortic smooth muscle cells, which are impli-
cated in TLOs in atherosclerosis (Grabner et al., 2009), to express
some genes characteristic of LTos, including CXCL13 and VCAM-
1. Both CXCL13 (Hjelmstrom et al., 2000) and VCAM-1 (Kratz
et al., 1996) have been observed in TLOs. However, it is possible
that signals from other cells could take over the function of LTos
in adult TLOs and LNs. Cells with LTi characteristics have been
noted inNOD (Evans andKim,2009) andRIPCXCL13 (Link et al.,
2011) pancreatic TLOs suggesting that they may play a role in the
development of these ectopic tissues.
FOLLICULAR DENDRITIC CELLS
Follicular DCs form a network supporting B cell follicles in LNs.
They are characterized by expression of complement receptors
(CR1 and CR2), FcγRIIb, and markers deﬁned by the antibodies
FDCM1, FDCM2, and C4. Their roles include capture of antigen–
antibody complexes for presentation to B cells and expression of
the chemokine, CXCL13, which draws B cells and T follicular
helper cells to the follicles via CXCR5.
Follicular DCs (FDCM1+CR1+) have been noted in TLOs.
Their reticular network and association with B cells (Dray-
ton et al., 2003) in TLOs suggest functional similarities with
SLOs. As noted above, CXCL13 is found in TLOs, includ-
ing those associated with Helicobacter pylori (Mazzucchelli et al.,
1999), rheumatoid arthritis (Loetscher and Moser, 2002), Sjö-
gren’s syndrome (Barone et al., 2005), inﬂammatory transgenes
(Kratz et al., 1996; Hjelmstrom et al., 2000; Drayton et al.,
2003), and cancer (Bergomas et al., 2012). However, although
FDCs are a major source of CXCL13 in LNs, monocytes and
macrophages have also been shown to secrete this chemokine
in the TLOs associated with rheumatoid arthritis and ulcera-
tive colitis (Carlsen et al., 2004), suggesting additional chemokine
sources in chronic inﬂammation, including LTo cells as noted
above. Antigen presentation by FDCs has not been investigated
in TLOs.
FIBROBLASTIC RETICULAR CELLS AND CONDUITS
The T cell zone of SLOs contains a dense, three-dimensional net-
work of stromal cells called FRCs. This subset of LN stromal cells
expresses podoplanin (gp38) but not the lymphatic and blood
endothelial cell marker, PECAM (CD31; Turley et al., 2010). FRCs
produce the extracellular matrix scaffolding that forms a series of
very ﬁne microvessels called conduits, detected using an antibody
(ER-TR7) that recognizes an undeﬁned antigen (Katakai et al.,
2004). Conduits extend from the subcapsular sinus through the
LN cortex, with greatest density in the paracortical T cell zone,
and terminate at HEVs. These microchannels are approximately
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4–5 nm in diameter and contain a dense network of collagen
ﬁbers that collectively limit access to molecules over 70 kDa in size
(Sixt et al., 2005).
In addition to their role in forming conduits, FRCs also par-
ticipate in the establishment and organization of lymphoid organ
microenvironments (reviewed in Turley et al., 2010). They are the
primary source of the T cell zone-restricted chemokines CCL19
and CCL21, both ligands for CCR7, present on T cells and DCs.
These chemokines establish the T zone boundary, facilitate T cell
and DC recruitment, and enhance DC maturation and function.
FRCs also produce IL-7, critical for naïve T cell survival. The FRC
network forms the three-dimensional scaffold along which T cells
and DCs migrate; via their shared association with FRCs, interac-
tions between naïve T cells andDCs expressing cognate antigen are
facilitated. FRCs express transcripts for some self-antigens and it is
has been suggested that they may be involved in self-tolerance (Lee
et al., 2007). Additional LN stromal cells, termed eTACs, which are
gp38−ERTR-7−, have also been reported to present self-antigens
(Gardner et al., 2008).
Conduits (Anderson and Anderson, 1975) are believed to serve
three key roles in SLOs (reviewed in Mueller and Ahmed, 2008).
Given their narrow diameter and positioning, conduits can fun-
nel small lymph-borne antigens from afferent lymphatics to the
T cell zone, where FRC-associated resident DCs can receive them.
Movement through these microvessels is much more rapid than
that which could be achieved by simple ﬁltration through the cell-
dense tissue of the LN. Although this reticular network is less
dense in the B cell zone, conduits may also serve as a pathway for
low molecular weight antigens to reach follicles and facilitate B
cell responses (Roozendaal et al., 2009). Finally, conduits serve as
channels for transmitting small molecule chemical signals, such
as chemoattractants from the surrounding tissue, to the paracor-
tical region of the LN, ultimately reaching the endothelial cells
lining HEVs.
Fibroblastic reticular cells and conduit-like structures havebeen
noted in several studies of TLOs. Link et al. (2011) visualized
these stromal elements using two-photon microscopy to detect
injected low molecular weight ﬂuorescent dyes, as well as via con-
focal microscopy and staining with ER-TR7 antibody. In TLOs
from NOD or rat insulin promoter (RIP) LTα and RIPCXCL13
transgenic mice FRC-like stromal cells were observed, with the
greatest density of staining in the T cell enriched areas of the
TLO. In another study of NOD mice, ER-TR7 reactivity was
found surrounding pancreatic islets and throughout the acinar
tissue, consistent with the expression of this marker on ﬁbrob-
lasts. However, it was also found within the inﬁltrate (Penaranda
et al., 2010), suggesting a supporting stromal network does exist
in this case as well. Likewise, using ﬂuorescently labeled ER-
TR7 antibodies, we have observed dense staining patterns that
resemble conduits in the T cell rich areas of the kidney inﬁl-
trates of RIPLTα mice (Figure 2). However, similar, although
less dense, staining could also be seen in kidney samples from
control mice, consistent with this as a ﬁbroblast marker. Pul-
monary arteries of patients with idiopathic pulmonary arterial
hypertension who develop circulating autoantibodies to various
vascular self-antigen include TLO-like structures and ER-TR7
antibody positivity (Perros et al., 2012). In non-lymphoid human
tissues undergoing chronic inﬂammation (e.g., the liver of patients
with primary biliary cirrhosis or the salivary glands of Sjögren’s
patients), conduit-like gp38+CD31−LYVE-1− networks similar to
those in LNs were seen in most of the T cell dense regions, but not
in control tissues.
Although cells with the characteristics of FRCs have been
observed in TLOs, their functions are unclear. In the absence of
a deﬁning capsule and subcapsular sinus it is more difﬁcult to
appreciate these structures as conduits transporting low molecular
molecules. Whether they can secrete tissue-organizing cytokines,
serve as scaffolding for the migration of T and B cells or chan-
nel low molecular weigh substances toward TLO compartments
remain unanswered questions. Cells phenotypically similar to
eTACs have been noted in NOD pancreatic TLOs (Gardner et al.,
2008) raising the question as to whether self-antigen presenta-
tion by stromal cells occurs in TLOs and exacerbates or induces
tolerance in those locations.
LYMPHATIC VESSELS
Afferent LVs deliver antigen and APCs to LNs and efferent vessels
serve as routes for cell trafﬁc to downstream LNs. Recently, an
FIGURE 2 | Presumptive conduit in a RIPLTαTLO. Inﬁltrate of a RIPLTα mouse with a kidney inﬁltrate, stained with ER-TR7 (red;A) anti-CD3 (green; B). Note
the presence of the ﬁne network of ER-TR7+ cells underlying the inﬁltrate.
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additional LV function was described: expression of self-antigen
under the control of AIRE for presentation to T cells (Cohen et al.,
2010). In LNs,DCs accumulate in the subcapsular sinus and trans-
migrate through the ﬂoor of that sinus into the T cell zone, while
T cells access the parenchyma of the LN through the peripheral
medullary sinuses (Braun et al., 2011). Egress from the LN is reg-
ulated in part by the high concentration of S1P in the lymph
and the re-expression of the receptor, S1P1, on T cells as they
leave the node and enter into the efferent lymph (Cyster and
Schwab, 2012).
The presence of vessels with typical lymphatic markers,
including LYVE-1 and Prox1, has been documented in the
TLOs arising in both clinical settings (autoimmune disease and
chronic graft rejection) and experimental models (summarized
in Kerjaschki et al., 2004; Drayton et al., 2006; Furtado et al.,
2007; Liao et al., 2007; Grabner et al., 2009; Mounzer et al.,
2010). Although some macrophages also express LYVE-1, addi-
tional characteristics including gp38 expression, thin walls, and
absence of red blood cells convincingly demonstrate their identity
as LVs.
It has been suggested that TLOs differ from SLOs by the absence
of a capsule. Thus, the trafﬁcking patterns analogous to those
in LNs (Braun et al., 2011), with the DCs percolating and T
cells migrating through the peripheral medullary sinus to the
parenchyma,might not occur in TLOs. However, TLOs in a variety
of chronic kidney diseases (Mandache and Penescu, 2011) are in
contact with a ﬁbrous capsule, suggesting that, similar modes of
migration in TLOs may be possible.
Duringontogeny, LVsdevelop after the embryonic bloodvessels
have formed, sprouting off from the cardinal vein (Srinivasan et al.,
2007), orchestrated by the homeobox genes (Sox18 and Prox1)
and growth factors and their receptors (VEGFC and VEGFR3),
and requiring platelets (Abtahian et al., 2003). LTα (Mounzer et al.,
2010),DCs andTandBcells have been implicated in the regulation
of LVs in inﬂammation (Angeli et al., 2006; Liao and Ruddle, 2006;
Chyou et al., 2011). Regulation of lymphangiogenesis in TLOs is
less well understood, although DCs have been implicated in a
transgenic model of thyroiditis (Muniz et al., 2011). LTα regulates
LVs in RIPLTαTLOs with less dependence on the LTαβ complex
(Mounzer et al., 2010). On the other hand in the CXCL13 induced
model of thyroiditis, LVs are inhibited by treatmentwith a LTβR-Ig
(Furtado et al., 2007).
In some TLOs LVs are packed with lymphocytes (Liao et al.,
2007) suggesting that they may act to transport activated lym-
phocytes to downstream LNs, similar to their function in SLOs.
Continual administration of FTY720, an S1P receptor agonist
that prevents egress of lymphocytes from LNs (Mandala et al.,
2002), prevents diabetes in NOD mice (Penaranda et al., 2010).
This is only effective if the mice have already developed pan-
creatic TLOs. Treatment results in additional accumulation of
lymphocytes in the pancreatic TLOs, which is reversed upon ces-
sation, resulting in rapid islet destruction and diabetes. These
data suggest that lymphocyte trafﬁcking through LVs in TLOs
in NOD mice is under regulation of the lymph S1P gradi-
ent and expression of its receptor by T cells as in a canonical
LN. The recent advances in in vivo imaging of LNs with the
development of mice with red ﬂuorescent LVs (Truman et al.,
2012) may allow further analysis of the function of LVs in
TLOs.
HIGH ENDOTHELIAL VENULES
High endothelial venules, which are post-capillary venules with
cuboidal endothelium, are the sites of entry of naïve lympho-
cytes from the blood stream into LNs. This is accomplished by
the interaction of molecules on the surface of lymphocytes with
ligands expressed by HEVs. Peripheral node addressin (PNAd),
deﬁned by the MECA-79 antibody, is composed of any of a
variety of chemically modiﬁed core glycoproteins, including
GlyCAM-1, CD34, Sgp200, and podocalyxin, to become func-
tional L-selectin ligands (Rosen, 2004). The several enzymes that
mediate these post-translational modiﬁcations include FucT-IV,
FucT-VII, and GlcNAc6ST2 (also called HEC-6ST, LSST, GST-3,
HEC-GlcNAc6ST, gene name Chst4; Hiraoka et al., 1999, 2004;
Hemmerich et al., 2001a,b; Homeister et al., 2001), GlcNAc6ST2 is
uniquely expressed in high endothelial cells, with the exception of
a population of cells in the intestine (Liao et al., 2007; Kawashima
et al., 2009). Binding to PNAd slows down (tethers) L-selectinhi
lymphocytes in their progress through the blood vessels, allowing
interaction with chemokines and integrins, eventually facilitat-
ing migration of lymphocytes toward chemokines located in the
paracortical region (T cells, DCs) or cortex (B cells). PNAd
rapidly replaces MAdCAM-1 after birth in mouse peripheral LNs
(Mebius et al., 1997), but is expressed in mucosal LNs together
with MAdCAM-1, the ligand for the integrin α4β7.
High endothelial venules are prominent features of TLOs and
their presence can be considered the deﬁning characteristic that
distinguishes these organized structures from other forms of
inﬂammatory inﬁltrate, as they are so crucial for the entrance
of naïve cells. HEVs in TLOs (summarized in Drayton et al.,
2006) are characterized by expression of MAdCAM-1, PNAd, and
chemokines, particularly CCL21 (Hjelmstrom et al., 2000), as well
as the crucial sulfating enzyme GlcNAc6ST2 (Bistrup et al., 2004).
HEVs have also been noted in the inﬂammatory inﬁltrates associ-
ated with atherosclerosis (Grabner et al., 2009) and several tumors
(Martinet et al., 2011; Bergomas et al., 2012). In fact, the pres-
ence of high numbers of these vessels is associated with improved
clinical outcomes in breast cancer (longer disease free survival
and reduced metastases; Martinet et al., 2011), suggesting that the
HEVs in tumor TLOs could enhance the entrance and priming of
naïve lymphocytes into effector cells at the tumor site and lead to
improved outcome.
Regulation of HEVs in TLOs appears to be similar to that
in SLOs. In LNs, LTα3 regulates MAdCAM-1 (Cuff et al., 1998)
and the LTα1β2 complex regulates PNAd (Drayton et al., 2003,
2004; Browning et al., 2005) through the alternative NFκB path-
way (Drayton et al., 2004). An LTβ antagonist, LTβR-Ig, inhibits
HEVs in LNs (Browning et al., 2005; Liao and Ruddle, 2006; Liao
et al., 2007) and also in the TLOs that arise in salivary and lacrimal
glands of NOD mice (Fava et al., 2011a,b).
High endothelial venules function in LNs as entry sites for naïve
cells. A similar portal function is assumed in TLOs because of
the presence of naïve cells at those sites (Kratz et al., 1996) and
evidence of epitope spreading (Miller et al., 2007). However, the
actual migration of naïve lymphocytes from the blood stream via
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HEVs into the parenchyma has not yet been visualized in real
time in TLOs. Our development of mice with green ﬂuores-
cent HEVs (Bentley et al., 2011) and their in vivo imaging in
LNs (Truman et al., 2012) will enable similar analysis in TLOs
and resolve whether HEVs function as entry points for naïve
cells.
IMPLICATIONS
A better understanding of the stromal structure in TLOs could
lead theway to therapeutics directed speciﬁcally at such structures.
Likewise, a clearer appreciation of the inﬂammatory signals that
drive the organization of stromal cells in non-lymphoid tissues
into TLO-like structures might allow the design of therapeutic
interventions to impede the progression of chronic inﬂamma-
tion, including autoimmune activity. Local interference with the
chemokine signals that recruit and organize T and B cells into
functional pro-inﬂammatory structures in non-lymphoid tissues
might dampenautoimmune responses andallow formore effective
conventional therapy for autoimmune diseases. Since regulatory
T cells have been observed in some TLOs, a better understand-
ing of and ability to enhance the tolerance inducing capabilities
of APCs might help restrain self-reactivity, limiting exacerba-
tion of autoimmune disease. Treatment with agents that enhance
the alternative NF-κB pathway could encourage the development
of HEVs in tumors, enhancing the entrance of naïve cells and
providing useful new strategies in cancer. Although this concept
is actually in contradistinction to treatments currently used to
prevent angiogenesis in the tumor setting, understanding the
complexity of the stroma in TLOs could provide creative new
approaches to disease control.
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